The Medical Journal of Australia · 2003 · 169 citations · 29 references
MedicineHealth Services AdministrationPsychiatryBehavioral HealthDementiaGeriatric CareBehavioral SymptomsDementia CareDementia PreventionDementia TreatmentIntegrated Behavioral Health CareBehavioral Management In DementiaBehavioral Symptoms TreatmentComprehensive Planning ProcessDementia Care PolicyDementia-related Behavioral Symptom ManagementPsychological Symptom ManagementService Delivery Organization
People with dementia commonly experience BPSD, yet in Australia there is insufficient planning and uneven resource distribution for managing and preventing these symptoms. The authors propose a seven‑tiered model of service delivery based on the severity and prevalence of BPSD, ranging from no dementia to extreme violence in a minority of cases. Each tier is linked to a distinct intervention approach, and patients can move up or down tiers as their condition, care, and interventions change. Lower‑level interventions may prevent the need for more intensive measures when behavioural disturbance becomes severe.
People with dementia usually experience behavioural and psychological symptoms of dementia (BPSD) during the course of their illness. Currently, in Australia, there is a lack of comprehensive planning for managing and preventing BPSD, and the resources required for optimal care are inadequate and unevenly distributed. We propose a seven-tiered model of service delivery based on severity and prevalence of BPSD, ranging from no dementia through tiers of increasingly severe behavioural disturbance to the propensity for extreme violence in a small number of individuals. Each tier is associated with a different model of intervention. People with dementia may move up or down between tiers depending on their condition, their care and the intervention provided. Lower-level interventions may prevent the need for the more intensive interventions needed when disturbance becomes more severe.
29
The spectrum of behavioral changes in Alzheimer's disease
Michael S. Mega, Jeffrey L. Cummings, Tara Fiorello et al. · Neurology · 1996 · 1.1K citations
Medicine, Neurology, Psychiatry +17
A 5-month, randomized, placebo-controlled trial of galantamine in AD
Pierre N. Tariot, Paul R. Solomon, Julie Morris et al. · Neurology · 2000 · 923 citations